DGAP-News: Epigenomics AG / Key word(s): Study results/Study10.08.2020 / 08:00 The issuer is solely responsible for the content of this announcement. New study published in the Journal of the National Cancer Institute concludes that Epi proColon(R) is the test of choice for the millions of individuals not willing to participate in FIT or colonoscopy screening […]
Category: Press Releases
10. August 2020
New study published in the Journal of the National Cancer Institute concludes that Epi proColon(R) is the test of choice for the millions of individuals not willing to participate in FIT or colonoscopy screening
Read more
16. June 2020
Epigenomics AG to Participate in Raymond James Human Health Innovations Conference
DGAP-News: Epigenomics AG / Key word(s): Conference/Miscellaneous16.06.2020 / 10:00 The issuer is solely responsible for the content of this announcement. Epigenomics AG to Participate in Raymond James Human Health Innovations Conference Berlin (Germany) and San Diego, CA (U.S.A.), June 16, 2020 – Epigenomics AG (FSE: ECX, OTCQX: EPGNY; the “Company”) today announced that company management […]
07. May 2020
Epigenomics AG Reports 2020 First Quarter Financial Results
DGAP-News: Epigenomics AG / Key word(s): Quarterly / Interim Statement/Quarter Results07.05.2020 / 08:17 The issuer is solely responsible for the content of this announcement. Epigenomics AG Reports 2020 First Quarter Financial Results Berlin (Germany) and San Diego, CA (U.S.A.), May 7, 2020 – Epigenomics AG (FSE: ECX, OTCQX: EPGNY, the “Company”) today announced financial results […]
29. April 2020
Epigenomics AG Reports Financial Results for Fiscal Year 2019 and Preliminary Unaudited Financial Results for the First Quarter of 2020
DGAP-News: Epigenomics AG / Key word(s): Annual Results29.04.2020 / 08:00 The issuer is solely responsible for the content of this announcement. Epigenomics AG Reports Financial Results for Fiscal Year 2019 and Preliminary Unaudited Financial Results for the First Quarter of 2020 Berlin (Germany) and San Diego, CA (USA), April 29, 2020 – Epigenomics AG (FSE: […]
24. April 2020
Epigenomics AG: Epi proColon included in 2020 National Comprehensive Cancer Network Colorectal Cancer Screening Guidelines
DGAP-News: Epigenomics AG / Key word(s): Miscellaneous/Scientific publication24.04.2020 / 07:33 The issuer is solely responsible for the content of this announcement. Epigenomics AG: Epi proColon included in 2020 National Comprehensive Cancer Network Colorectal Cancer Screening Guidelines Berlin (Germany), April 24, 2020 – Epigenomics AG (FSE: ECX, OTCQX: EPGNY; the “Company”) announced that Epi proColon, the […]
14. April 2020
Epigenomics AG implements comprehensive measures to reduce costs during the COVID-19 pandemic crisis
DGAP-News: Epigenomics AG / Key word(s): Miscellaneous14.04.2020 / 08:00 The issuer is solely responsible for the content of this announcement. Epigenomics AG implements comprehensive measures to reduce costs during the COVID-19 pandemic crisis Berlin (Germany), April 14, 2020 – Epigenomics AG (FSE: ECX, OTCQX: EPGNY; the “Company”) has initiated comprehensive measures to reduce costs in […]